أعرض في EDS

Initial results from AQUARiUS, a prospective, observational, multi-centre phase IV study assessing patient-reported outcomes (PROs) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate plus prednisone (AAP) or enzalutamide (ENZ)

التفاصيل البيبلوغرافية
العنوان:	Initial results from AQUARiUS, a prospective, observational, multi-centre phase IV study assessing patient-reported outcomes (PROs) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate plus prednisone (AAP) or enzalutamide (ENZ)
المؤلفون:	Guillaume Ploussard, Redas Trepiakas, A. Reid, Dominique Beal-Ardisson, Louis-Marie Dourthe, L. Dearden, Antoine Thiery-Vuillemin, Elias Pintus, Mads Hvid Poulsen, Edouard Lagneau, S. Van Sanden, A. Birtle, M Lukac
المصدر:	Annals of Oncology. 28:v287-v288
بيانات النشر:	Elsevier BV, 2017.
سنة النشر:	2017
مصطلحات موضوعية:	Oncology, medicine.medical_specialty, business.industry, Abiraterone acetate, Hematology, Castration resistant, medicine.disease, Surgery, chemistry.chemical_compound, Prostate cancer, chemistry, Prednisone, Internal medicine, medicine, Enzalutamide, Observational study, Multi centre, business, medicine.drug
تدمد:	0923-7534
DOI:	10.1093/annonc/mdx370.046
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::47b4c648873ac6242b4874e294505bab https://doi.org/10.1093/annonc/mdx370.046
Rights:	OPEN
رقم الانضمام:	edsair.doi...........47b4c648873ac6242b4874e294505bab
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	09237534
DOI:	10.1093/annonc/mdx370.046